[1] Ginsburg O,Bray F,Coleman MP,et al.The global burden of women's cancers:A grand challenge in global health[J].Lancet,2017,389(10071):847-860.
[2] Hanahan D,Weinberg RA.Hallmarks of cancer:The next generation[J].Cell,2011,144(5):646-674.
[3] Szkandera J,Gerger A,Liegl-Atzwanger B,et al.The lymphocyte/monocyte ratio predict poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas[J].Int J Cancer,2014,135(2):362-370.
[4] Ferlay J,Shin HR,Bray F,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
[5] Bradford L,Goodman A.Cervical cancer screening and prevention in low-resource settings[J].Clin Obstet Gynecol,2013,56(1):76-87.
[6] Balkwill F,Mantovani A.Inflammation and cancer:Back to virchow[J]?Lancet,2001,357(9255):539-545.
[7] Okada F.Inflammation-related carcinogenesis:Current findings in epidemiological trends,causes and mechanisms[J].Yonago Acta Med,2014,57(2):65-72.
[8] Kim S,Takahashi H,Lin WW,et al.Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis[J].Nature,2009,457(7225):102-106.
[9] Kantola T,Klintrup K,Vayrynen JP,et al.Stage-dependent alterations of the serum cytoline pattern in colorectal carcinoma[J].Br J Cancer,2012,107(10):1729-1736.
[10] Imtiaz F,Shafique K,Mirza SS,et al.Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian populmion[J].Int Arch Med,2012,5(1):2-4.
[11] Gondo T,Nakashima J,Ohno Y,et al.Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy[J].Urology,2012,79(5):1085-1091.
[12] Kobayashi N,Usui S,Kikuchi S,et al.Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer[J].Lung Cancer,2012,75(2):223-227.
[13] Raungkaewmanee S,Tangjitgamol S,Manusirivithaya S,et al.Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer[J].J Gynecol Oncol,2012,23(4):265-273.